WINDTREE THERAPEUTICS INC /DE/
WINT, WINTWOther · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $198,000 |
| Operating income | −$26.1M | −$20.6M | −$41.3M | −$77.3M | −$30.3M | −$24.9M |
| Net income | −$1.8M | −$20.3M | −$39.2M | −$67.6M | −$32.6M | −$27.5M |
| Total assets | $27.9M | $32.4M | $38.0M | $74.8M | $112.9M | $119.0M |
| Total liabilities | $14.7M | $29.0M | $27.9M | $32.9M | $43.3M | $44.0M |
| Equity | $10.0M | $3.4M | $10.0M | $41.9M | $69.6M | $74.9M |
| EPS (diluted) | $-104.35 | $-4718.84 | $-62.23 | $-136.64 | — | — |
| Shares out. | 9.2M | 909,013 | 28.5M | 26.3M | 41.1M | 13.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2024- Operating margin
- —
- Net margin
- —
- Return on equity
- −17.9%
- Return on assets
- −6.4%
- Return on capital (ROCE)
- −118.0%
- Liabilities / assets
- 52.7%
- Debt / equity
- 1.47×
- Book value / share
- $1.09
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2024- Altman Z″ (distress)
- -105.34distress
- Accruals / assets
- 48.8%high accruals
- Piotroski F-Score
- 2/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 2 warning● 0 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- High accruals — earnings-quality risk
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 1, 2026
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2025
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2025
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2024
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2024
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Fraser CraigOfficer — President and CEO | Oct 8, 2024 | Buy | 5,431 | $0.91 |
| Fraser CraigOfficer — President and CEO | Sep 27, 2023 | Buy | 2,500 | $1.02 |
| Fraser CraigOfficer — President and CEO | Sep 26, 2023 | Buy | 2,500 | $0.90 |
| Geffken Daniel E.Director | Aug 23, 2023 | Grant | 2,033 | $0.00 |
| Williams Leslie J.Director | Aug 23, 2023 | Grant | 2,033 | $0.00 |
| Strobeck MarkDirector | Aug 23, 2023 | Grant | 2,300 | $0.00 |
| Scott Robert ADirector | Aug 23, 2023 | Grant | 2,033 | $0.00 |
| Simonson StevenOfficer — SVP, Chief Medical Officer | Aug 23, 2023 | Grant | 15,867 | $0.00 |
| Curtis EricOfficer — SVP & COO | Aug 23, 2023 | Grant | 14,667 | $0.00 |
| Fraser CraigOfficer — President and CEO | Aug 23, 2023 | Grant | 45,867 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Director / officer changeJan 7, 2026
- New financial obligation · Unregistered equity saleDec 2, 2025
- New financial obligation · Unregistered equity saleOct 16, 2025
- Entered a material agreementOct 6, 2025
- Director / officer changeSep 8, 2025
- Shareholder voteSep 2, 2025
- Delisting / listing-standard noticeAug 20, 2025
- Other material eventAug 8, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- NT 10-KFORM NT 10-KApr 1, 2026
- 8-KFORM 8-KJan 7, 2026
- 8-KFORM 8-KDec 2, 2025
- 424B3FORM 424B3Nov 21, 2025
- 10-QFORM 10-QNov 19, 2025
- NT 10-QFORM NT 10-QNov 14, 2025
- 424B3FORM 424B3Nov 13, 2025
- S-1FORM S-1Oct 24, 2025
- 8-KFORM 8-KOct 16, 2025
- 8-KFORM 8-KOct 6, 2025
- 8-KFORM 8-KSep 8, 2025
- 8-KFORM 8-KSep 2, 2025
- 8-KFORM 8-KAug 20, 2025
- 10-QFORM 10-QAug 19, 2025
- NT 10-QFORM NT 10-QAug 14, 2025
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.